US Stock MarketDetailed Quotes

AKBA Akebia Therapeutics

Watchlist
  • 1.3400
  • +0.0100+0.75%
Close Oct 18 16:00 ET
  • 1.3400
  • 0.00000.00%
Post 20:02 ET
281.79MMarket Cap-6380P/E (TTM)

Akebia Therapeutics Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Akebia Therapeutics Earnings Estimates

Revenue

EPS

EBIT

Revenue is based on 3 analyst forecasts. Estimate data is from S&P, and actual data is from Income Statement

Currency: USD

Actual
Estimate
DatePeriodRevenue/EstimateEarnings Call
--2024/Q4-- / 51.225M--
--2024/Q3-- / 44.505M--
Aug 8, 20242024/Q243.648M / 43.653M--
May 9, 20242024/Q132.607M / 46.087M--
Mar 14, 20242023/Q456.196M / 55.393M--
DatePeriodRevenue/EstimateEarnings Call
--2024/Q4-- / 51.225M--
--2024/Q3-- / 44.505M--
Aug 8, 20242024/Q243.648M / 43.653M--
May 9, 20242024/Q132.607M / 46.087M--
Mar 14, 20242023/Q456.196M / 55.393M--

Unlock Free Earnings Estimates

Akebia Therapeutics Earnings Reports

  • Akebia Therapeutics | 10-Q: Q2 2024 Earnings Report

    Aug 8 07:54 ET

  • Akebia Therapeutics | 10-Q: Q1 2024 Earnings Report

    May 9 07:07 ET

  • Akebia Therapeutics | 10-K: FY2023 Annual Report

    Mar 14 17:21 ET

  • Akebia Therapeutics | 10-Q: Q3 2023 Earnings Report

    Nov 8, 2023 07:45 ET

    • Read more

    Analysis

    Analyst Rating

    Updated: Sep 30, 2024

    Buy

    • Buy

      100.00%

    • Hold

      0.00%

    • Sell

      0.00%

    Price Target

    No Data

    Heat List
    US
    Overall
    Symbol
    Latest Price
    % Chg

    No Data